Phase III trial of SABER-bupivacaine (Posidur) for pain relief in patients with soft tissue injuries
Latest Information Update: 26 May 2015
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain; Soft tissue injuries
- Focus Adverse reactions; Registrational
- Sponsors DURECT Corporation
Most Recent Events
- 26 May 2015 New trial record